Zenas BioPharma, Inc. (ZBIO)

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Immune-based Therapies	5.00M	Log In
Immune-based Therapies Growth	-90.00%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
United States	5.00M	Log In
United States Growth	-90.00%	Log In